Document is current
Any future updates will be listed below
-
Authors
Rolland, Yves http://orcid.org/0009-0003-9486-9144
Sierra, Felipe
Ferrucci, Luigi http://orcid.org/0000-0002-6273-1613
Barzilai, Nir
De Cabo, Rafael
Mannick, Joan
Oliva, Anthony
Evans, William
Angioni, Davide
De Souto Barreto, Philipe
Raffin, Jeremy
Vellas, Bruno
Kirkland, James L. http://orcid.org/0000-0003-1676-4905
,
Andrieu, Sandrine
Bacqueville, Daniel
Bischoff-Ferrari, Heike
Blivet, Guillaume
Cash, Timothy
Cuervo, Ana-Maria
Davezac, Noelie
Dimet-Wiley, Andrea
Fleming, Alexander
Gérard, Friedlander
Gonzales, Mitzi
Guyonnet, Sophie
Hare, Joshua
Hendrix, Suzanne
Jorgensen, Christian
Kaeberlein, Matt
Khan, Mehmood
Kritchevsky, Stephen
Labokha, Aksana
Lairez, Olivier
Lederman, Stephanie
Mariani, Jean
Middleton, Lefkos
Newman, John
Parini, Angelo
Peschin, Susan
Prunotto, Marco
Sagol, Sami
Tomlinson, Suzanne
Terstappen, Georg
Touchon, Jacques
Tourette, Cendrine
Van Maanen, Rob
Verdin, Eric
Watowich, Stan
Zhang, Lei
Zhavoronkov, Alex
- License Information
-
More Information
Article History
Received: 20 February 2023
Accepted: 29 June 2023
First Online: 19 August 2023
Competing interests
: The views expressed in the manuscript the personal views of the authors and may not be understood as being made on behalf of organizations with which the authors are affiliated. Y.R. reports support from CHU Toulouse, University Paul Sabatier, INSERM CERPOP1295 (Employee), to be a shareholder of SARQOL SPRL, a spin-off of the University of Liege, consultancy fees from Longeveron, Biophytis, and honoraria for lectures for Pfizer. N.B. reported grants from the National Institutes of Health (P01AG021654) (N.B.), the Nathan Shock Center of Excellence for the basic Biology of Aging (P30AG038072) (N.B.), the Einstein-Paul Glenn Foundation for Medical Research Center for the Biology of Human Aging (N.B.), and taking part to advisory boards of Longevity Biotceh Association and Health Longevity Medical Society. A.O. reports support from Longeveron (Employee) and grants from National Institute on Aging (NIA)/National Institutes of Health (NIH) and Alzheimer’s Association. WE reports grants from the National Institutes of Health (1R01AG059416, R01CA246695, 5R01AG055443-02, 1R01AG065265, UCB 20210962, UCB 20210962, R01 AG074956-01, 1U01CA271277-01, 1R37CA258761-01A1) and consulting fees from BioAge Labs. B.V. reports support from CHU Toulouse, University Paul Sabatier and INSERM CERPOP1295 (employee), grant from Pfizer, Pierre Fabre. J.K. reports grants from US NIH paid to Mayo Clinic (grant R01AG 072301, P01AG 062413, R37AG 13925, R33AG 61456, R01AG 64165, R01AG 55529, R01DK 120292, R01DK 119167, R01HL 141819, R01AG 68048, UH3AG 56933 U54AG 075941, UG3CA 268103, R25AG 073119, R01AG 61414) and the Alzheimer’s Association (PTC REG-20-651687), consulting fees from Oklahoma Medical Research Foundation Scientific Advisory Board, and Henry Ford Health System, support for attending meetings (travel expense reimbursement) from AFAR, FASEB meeting, American Thoracic Society 2022 International Conference, Association for Research in Vision and Ophthalmology, Oriel College (Oxford University), 12th International Conference on Frailty and Sarcopenia Research (Boston), University of California (San Diego), Harvard University, 2nd Euro Geroscience Conference (Toulouse), University of North Carolina, University of Kansas Medical Center, Steadman Clinic (Vail), Gerontological Society of American, Longevity Medicine Society, patents (planned, issued, or pending/rights held by Mayo Clinic), and leadership at the American Federation for Aging Research board. Other authors (F.S., L.F., R.d.C., J.M., D.A., P.d.S.B., and J.R.) report no conflicts of interest.
